(S)-3-(Pyrrolidin-3-yl)-3,4-dihydroquinazolin-2(1H)-one hydrochloride

Catalog No.: 
ACOWQZ735
CAS No.: 
1389310-29-5
Molecular Formula: 
C12H16ClN3O
Molecular Weight: 
253.73
(S)-3-(Pyrrolidin-3-yl)-3,4-dihydroquinazolin-2(1H)-one hydrochloride structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg97%$249.00InquiryInquiry
1g97%$711.00InquiryInquiry
5g97%$3519.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(S)-3-(Pyrrolidin-3-yl)-3,4-dihydroquinazolin-2(1H)-one hydrochloride
IUPAC Name(S)-3-(pyrrolidin-3-yl)-3,4-dihydroquinazolin-2(1H)-one hydrochloride
MDL No.MFCD22375763
Molecular FormulaC12H16ClN3O
Molecular Weight253.73
SMILESO=C1NC2=C(C=CC=C2)CN1[C@@H]3CNCC3.[H]Cl
InChI KeyYUEKVTVGEZSGNJ-PPHPATTJSA-N
Synonym3-[(3S)-Pyrrolidin-3-yl]-1,2,3,4-tetrahydroquinazolin-2-one hydrochloride;(S)-3-(pyrrolidin-3-yl)-3,4-dihydroquinazolin-2(1H)-one hydrochloride
CAS No.1389310-29-5

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACOWQZ735 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACOWQZ735 route product structure diagram
    ACOWQZ7351389310-29-5
Inquiry

2. ACOWQZ735 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACOWQZ735 route product structure diagram
    ACOWQZ7351389310-29-5
Inquiry

3. ACOWQZ735 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACOWQZ735 route product structure diagram
    ACOWQZ7351389310-29-5
Inquiry

Comments (0)